Search results
Results from the WOW.Com Content Network
An older term, febricula (a diminutive form of the Latin word for fever), was once used to refer to a low-grade fever lasting only a few days. This term fell out of use in the early 20th century, and the symptoms it referred to are now thought to have been caused mainly by various minor viral respiratory infections .
Infectious mononucleosis (IM, mono), also known as glandular fever, is an infection usually caused by the Epstein–Barr virus (EBV). [2] [3] Most people are infected by the virus as children, when the disease produces few or no symptoms. [2] In young adults, the disease often results in fever, sore throat, enlarged lymph nodes in the neck, and ...
Infectious mononucleosis, most commonly caused by EBV, may present as a fever of unknown origin. Other symptoms of infectious mononucleosis vary with age with middle-aged adults and the elderly more likely to have a longer duration of fever and leukopenia, and younger adults and adolescents more likely to have splenomegaly, pharyngitis and ...
Symptoms of pneumonia in the elderly may vary depending on the type of pneumonia and the overall health of the person. While not all of these may be present, the symptoms of pneumonia in seniors ...
A fever is usually a sign of an infection, and it often comes with other symptoms instead of just having a high temperature. But having a fever means you should at least keep closer tabs on your ...
In fact, she says that RSV causes over 60,000 hospitalizations and between 6,000 and 10,000 deaths among seniors 65 or older every year. What Are the Symptoms of RSV in Older Adults? Symptoms of ...
Hyperthermia is generally diagnosed by the combination of unexpectedly high body temperature and a history that supports hyperthermia instead of a fever. [2] Most commonly this means that the elevated temperature has occurred in a hot, humid environment (heat stroke) or in someone taking a drug for which hyperthermia is a known side effect ...
What’s more, RSV vaccines are now available for infants at high risk of severe disease, pregnant women from 32–36 gestational weeks, and adults 60 years of age and older.